Can CHD run in families? 

Yes, congenital heart disease (CHD) can run in families, although the majority of cases occur sporadically with no prior family history. If a parent or a previous child has been born with a heart defect, the statistical risk for future children increases slightly. This hereditary link is often due to shared genetic factors or specific chromosomal conditions that can be passed down through generations. However, even with a family history, most babies are still born with a healthy heart. 

What We will cover in this Article 

• ‘The statistical risk of CHD based on family history’ 

• ‘The role of inherited genetic mutations’ 

• ‘Chromosomal conditions and their hereditary patterns’ 

• ‘The difference between inherited and spontaneous defects’ 

• ‘How family history influences prenatal screening’ 

• ‘Guidance on genetic counselling for families’ 

Understanding the Hereditary Link 

Congenital heart disease is a structural problem present from birth. While environmental factors play a role, genetics are a key driver. When we say CHD ‘runs in families,’ we are referring to the fact that certain genetic blueprints for building the heart can be inherited. 

In the general UK population, the risk of a baby being born with CHD is about 1 in 100 (1%). If one parent has a heart defect, that risk typically rises to between 2% and 15%, depending on the specific type of defect and which parent is affected. 

Risk Factors Based on Family Members 

The risk of CHD is not uniform; it depends heavily on which family member has the condition. Clinical data suggests that maternal history often carries a slightly higher risk than paternal history. 

Affected Family Member	Estimated Risk for the Baby
General Population	~1%
One Sibling affected	2% – 3%
Father affected	2% – 3%
Mother affected	5% – 15%
Two Siblings affected	~10%

These percentages are general estimates. Some specific conditions, such as Marfan syndrome or certain types of cardiomyopathies, follow an autosomal dominant pattern, meaning there is a 50% chance of passing the condition to each child. 

Inherited vs. Spontaneous Defects 

It is important to distinguish between defects that are part of the family DNA and those that happen ‘by chance’ during the baby’s development. 

• Inherited Mutations: These are passed from a parent to a child. The parent may have a manifest heart defect, or they may simply be a ‘carrier’ of a gene that doesn’t affect them but can affect their offspring. 

• Spontaneous (De Novo) Mutations: These are new genetic changes that occur in the egg, sperm, or shortly after conception. There is no family history, and the risk of it happening again in a future pregnancy is usually very low. 

Genetic Syndromes and CHD 

Sometimes, CHD runs in families as part of a broader genetic syndrome. These syndromes affect multiple parts of the body, including the heart. 

• DiGeorge Syndrome (22q11.2 deletion): Often causes defects in the heart’s outgoing vessels and can be inherited from a parent who has a very mild, undiagnosed version. 

• Noonan Syndrome: A relatively common condition that can cause pulmonary valve stenosis and is often passed down through families. 

• Holt-Oram Syndrome: Characterised by ‘holes in the heart’ and skeletal issues in the arms or hands. 

To Summarise 

Congenital heart disease can run in families, and having a close relative with a heart defect does increase the statistical risk for future children. However, the overall risk remains relatively low for most families. By using genetic counselling and advanced prenatal screening, the NHS helps families understand their specific risks and ensures that babies with a potential heart condition receive the best possible care from the moment they are born. 

If you experience severe, sudden, or worsening symptoms, such as your baby turning blue, gasping for air, or becoming unresponsive, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

‘This article was reviewed by Dr. Stefan Petrov, a UK-trained physician with experience in general medicine, surgery, and emergency care. Dr. Petrov’s clinical background includes performing diagnostic procedures and managing cardiac presentations in hospital settings. His expertise ensures this guide to the hereditary aspects of CHD is accurate and follows the 2026 NHS and NICE safety frameworks.’ 

Evidence and Clinical Data 

Current UK clinical practice prioritises early screening for families with a known history of heart defects. 

‘Advanced genomic sequencing has revealed that inherited genetic factors contribute to approximately 20% of all congenital heart disease cases. Families with a known history of CHD are now routinely offered specialist foetal echocardiography at 18 to 20 weeks, which increases the detection rate of major defects to over 90%.’ 

— National Health Service (NHS) Genomic Medicine Service, 2025 Clinical Audit. 

[Source: https://www.england.nhs.uk/genomics/] 

Key Statistics 

• Screening Success: Foetal echocardiograms are highly effective at identifying structural issues in high-risk families before birth. 

• Recurrence: The risk of recurrence is highest when the mother has the defect, particularly in cases of left-sided heart obstructions. 

• Emergency Advice: If a baby with a family history of CHD shows any sign of blue lips, fast breathing, or becomes unresponsive, call 999 immediately.